These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18663983)

  • 1. [COMETE, a network for the study and management of hypersecreting adrenal tumors].
    Plouin PF; Gimenez-Roqueplo AP; Bertagna X
    Bull Acad Natl Med; 2008 Jan; 192(1):73-82; discussion 83-5. PubMed ID: 18663983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Achievements of the COMETE program in the genetics of pheochromocytoma].
    Gimenez-Roqueplo AP; Burnichon N; Amar L; Favier J; Jeunemaitre X; Plouin PF
    Bull Acad Natl Med; 2008 Jan; 192(1):105-15; discussion 115-6. PubMed ID: 18663985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
    Feng C; Li HZ; Yan WG; Luo YF; Cao JL
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of argyrophilic proteins from the nucleolar organizer regions as an index of maturity degree of benign and malignant adrenal tumors].
    Raĭkhlin NT; Bukaeva IA; Baronin AA; Probatova NA; Smirnova EA; Bronshteĭn MI
    Arkh Patol; 2002; 64(3):26-30. PubMed ID: 15338720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paragangliomas: etiology, presentation, and management.
    Joynt KE; Moslehi JJ; Baughman KL
    Cardiol Rev; 2009; 17(4):159-64. PubMed ID: 19525677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
    Takahashi K; Totsune K; Saruta M; Fukuda T; Suzuki T; Hirose T; Imai Y; Sasano H; Murakami O
    Peptides; 2006 Jan; 27(1):178-82. PubMed ID: 16095756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenal incidentalomas: report of 126 cases].
    Li HZ; Yan WG; Wang W; Xia M; Wang HJ; Liu GH
    Zhonghua Wai Ke Za Zhi; 2004 Jan; 42(2):97-9. PubMed ID: 15009991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Causes of recurrence of patients with chromaffin tumors].
    Bel'tsevich DG; Kuznetsov NS
    Khirurgiia (Mosk); 2002; (8):19-23. PubMed ID: 12389495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy in pheochromocytomas.
    Salmenkivi K; Heikkilä P; Haglund C; Arola J
    APMIS; 2004 Sep; 112(9):551-9. PubMed ID: 15601303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues.
    Morimoto R; Satoh F; Murakami O; Totsune K; Arai Y; Suzuki T; Sasano H; Ito S; Takahashi K
    Peptides; 2008 May; 29(5):873-80. PubMed ID: 17686550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.
    Khorram-Manesh A; Ahlman H; Jansson S; Nilsson O
    Endocr Pathol; 2002; 13(2):99-110. PubMed ID: 12165657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical techniques for adrenal tumors.
    Broome JT; Gauger P
    Minerva Endocrinol; 2009 Jun; 34(2):185-93. PubMed ID: 19471241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension in patients with undifferentiated adrenal tumors].
    Dzizinskiĭ AA; Kulikov LK; Bykova NM; Privalov IuA
    Ter Arkh; 2002; 74(9):60-3. PubMed ID: 12418123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible applications of functional genomics in the study of the pathogenesis of adrenal and pituitary tumors].
    Péter S; Rácz K; Tulassay Z; Igaz P
    Orv Hetil; 2006 Jul; 147(27):1267-71. PubMed ID: 16927882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research about treatment for adrenal incidentalomas].
    Liu XK; Liu XJ; Dong X; Kong CZ
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(11):832-4. PubMed ID: 19035218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma: current approaches and future directions.
    Adler JT; Meyer-Rochow GY; Chen H; Benn DE; Robinson BG; Sippel RS; Sidhu SB
    Oncologist; 2008 Jul; 13(7):779-93. PubMed ID: 18617683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursor lesions of the adrenal gland.
    van Nederveen FH; de Krijger RR
    Pathobiology; 2007; 74(5):285-90. PubMed ID: 17890895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of adrenal tumors.
    Opocher G; Schiavi F; Cicala MV; Patalano A; Mariniello B; Boaretto F; Zovato S; Pignataro V; Macino B; Negro I; Mantero F
    Minerva Endocrinol; 2009 Jun; 34(2):107-21. PubMed ID: 19471236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.